Patent Assignment
Reel/Frame 045759/0682
Intellectual Property Security Agreement
Recorded: 2018-03-28
Pages: 33
Assignor
MESOBLAST, INC.
Executed: 2018-03-26
Assignee
HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Properties
(40)
Mesenchymal Precursor Cell
Patent:
7,122,178 →
Application:
10/030,411 →
Perivascular Mesenchymal Precursor Cells
Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation
Mesenchymal Precursor Cell
Mesenchymal Precursor Cell
Mesenchymal Precursor Cell
Perivascular mesenchymal precursor cell induced blood vessel formation
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Methods of Generating, Repairing and/or Maintaining Connective Tissue in Vivo
Mesenchymal Precursor Cell
Repair and/or Reconstitution of Invertebral Discs
Monoclonal Antibody Stro-4
Expansion of Haemopoietic Precursors
Method for Treating or Preventing a Pancreatic Dysfunction
Production of Reprogrammed Pluripotent Cells
Mesenchymal Precursor Cell
Method of Treating Graft Versus Host Disease
Mesenchymal Precursor Cell
Methods for Treating Obesity and/or Metabolic Syndrome
Methods of Treating Multiple Sclerosis Using Stro-1+ and Tnap+ Multipotential Cells
Methods of Treating or Preventing Rheumatic Disease
Methods for Increasing Osteoblastic Function
Method of Increasing Proliferation of Bone Marrow Mononuclear Cells Expressing STRO1-Dim
Expansion of Haemopoietic Precursors
Repair and/or Reconstitution of Invertebral Discs
Application:
14/504,308 →
Publication:
US 2015/0044186
Method for Treating Diabetic Renal Failure or Syndrome X
Methods of Treating or Preventing Respiratory Conditions
Treatment of Diseases of Endothelial Dysfunction and Inflammation
Application:
14/650,172 →
Publication:
US 2016/0175360
Perivascular Mesenchymal Precursor Cells
Monoclonal Antibody Stro-4
Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation
Application:
14/871,234 →
Publication:
US 2016/0317581
Methods of Treating or Preventing Rheumatic Disease
Method of Treating Graft Versus Host Disease
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Methods for Treating Obesity and/or Metabolic Syndrome
Methods of Generating, Repairing and/or Maintaining Connective Tissue in Vivo
Application:
15/177,708 →
Publication:
US 2017/0157181
Method for Treating or Preventing a Pancreatic Dysfunction
Methods for Increasing Osteoblastic Function
Application:
15/485,637 →
Publication:
US 2017/0274016
Treatment of T-Cell Mediated Immune Disorders
Application:
15/595,719 →
Publication:
US 2017/0258846
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Application:
15/651,469 →
Publication:
US 2018/0009905
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
May 10, 2012
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 028192/0789 →
Security Interest
Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Release of Intellectual Property Security Agreement at Reel/Frame No. 45759/0682
Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST, INC.
Reel/Frame 072294/0555 →
Release of Security Interest in Intellectual Property
Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →